Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention

Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention

Abstract Backgrounds Diabetes mellitus is an independent risk factor for Contrast-induced nephropathy (CIN) in patients undergoing Coronary arteriography (CAG)/percutaneous coronary intervention (PCI). Glycosylated hemoglobin (HbA1c) is the gold standard to measure blood glucose control, which has i...

Full description

Bibliographic Details
Main Authors: H. Zhang, H. Fu, X. Fu, J. Zhang, P. Zhang, S. Yang, Z. Zeng, N. Fu, Z. Guo
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Nephrology
Subjects:
Diabetes mellitus
Glycosylated hemoglobin
Percutaneous coronary intervention
Contrast-induced nephropathy
Risk factors
Online Access:https://doi.org/10.1186/s12882-021-02405-y

Similar Items

Similar Items